Dr. Sunil J. Wimalawansa
My Social Links

Dr. Sunil J. Wimalawansa

Professor
Cardio Metabolic Institute, USA


Highest Degree
Ph.D. in Endocrine Pathology from University of London, UK

Share this Profile

Area of Interest:

Biomedical Sciences
100%
Cadiovascular Sciences
62%
Drug Formulation
90%
Osteopososis
75%
Cell Biology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Wimalawansa, S.J., 2016. Vitamin D deficiency is a surrogate marker for visceral fat content, metabolic syndrome, type 2 diabetes and future metabolic complications. J. Diabetes Metab. Disorders Control, 3: 1-10.
  2. Wimalawansa, S.J., 2016. Vitamin D adequacy and improvements of comorbidities in persons with intellectual developmental disabilities. J. Childhood Dev. Disorders, Vol. 2. 10.4172/2472-1786.100030.
    CrossRef  |  Direct Link  |  
  3. Wimalawansa, S.J., 2016. The role of ions, heavy metals, fluoride and agrochemicals: Critical evaluation of potential aetiological factors of chronic kidney disease of multifactorial origin (CKDmfo/CKDu) and recommendations for its eradication. Environ. Geochem. Health, 38: 639-678.
    CrossRef  |  PubMed  |  Direct Link  |  
  4. Wimalawansa, S.J., 2016. Optimum duration and safety of long-term use of potent anti-resorptive medications in osteoporosis. Expert Rev. Endocrinol. Metab., 11: 329-348.
    CrossRef  |  Direct Link  |  
  5. Wimalawansa, S.J., 2016. Non-musculoskeletal benefits of vitamin D. J. Steroid Biochem. Mol. Biol., 10.1016/j.jsbmb.2016.09.016.
    CrossRef  |  PubMed  |  Direct Link  |  
  6. Wimalawansa, S.J., 2016. Extra-Skeletal benefits, Endocrine Functions and Toxicity of Vitamin. J. Endocrinol. Diabetes, 3: 1-5.
  7. Wimalawansa, S.J., 2016. Endocrinological mechanisms of depressive disorders and ill health. Expert Rev. Endocrinol. Metab., 11: 3-6.
    CrossRef  |  Direct Link  |  
  8. Wimalawansa, S.J., 2016. Effect of water hardness on non-communicable diseases, including chronic kidney disease of multifactorial origin (CKDmfo/CKDuo). J. Environ. Health Sci., 2: 1-11.
    CrossRef  |  Direct Link  |  
  9. Wimalawansa, S.J., 2016. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes and metabolic syndrome. J. Steroid Biochem. Mol. Biol., 10.1016/j.jsbmb.2016.09.017.
    CrossRef  |  PubMed  |  Direct Link  |  
  10. Wimalawansa, S.A. and S.J. Wimalawansa, 2016. Environmentally induced, occupational diseases with emphasis on chronic kidney disease of multifactorial origin affecting tropical countries. Ann. Occup. Environ. Med., Vol. 28. 10.1186/s40557-016-0119-y.
    CrossRef  |  PubMed  |  Direct Link  |  
  11. Smith, G., S.J. Wimalawansa, A. Laillou, P. Sophonneary and S. Un et al., 2016. High prevalence of vitamin D deficiency in Cambodian women: A common deficiency in a sunny country. Nutrients, Vol. 8. 10.3390/nu8050290.
    CrossRef  |  PubMed  |  Direct Link  |  
  12. Haq, A., S.J. Wimalawansa, P. Pludowski and F. Al Anouti, 2016. Clinical practice guidelines for vitamin D in the United Arab Emirates. J. Steroid Biochem. Mol. Biol., 10.1016/j.jsbmb.2016.09.021.
    CrossRef  |  PubMed  |  Direct Link  |  
  13. Camacho, P.M., S.M. Petak, N.C. Binkley, T. Harris and M. Kleerekoper et al., 2016. American associationof clinical endocrinologists and American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2016-executive summary. Endocr. Pract., 22: 1111-1118.
    CrossRef  |  Direct Link  |  
  14. Wimalawansa, S.J., 2015. Strategic framework for managing non-communicable diseases: Preventing chronic kidney disease of multi-factorial origin (CKDmfo / CKDu) as an example. Chronic Dis. Int., 2: 1-8.
  15. Wimalawansa, S.J., 2015. Preventing long-term complications of obesity, type 2 diabetes and metabolic syndrome. Endocrinol. Metab. Syndrome, Vol. 4. 10.4172/2161-1017.1000206.
    CrossRef  |  Direct Link  |  
  16. Wimalawansa, S.J., 2015. Obesity and type 2 diabetes: Preventing complications. J. Diabetes Metab. Disorders Control, 2: 47-50.
    CrossRef  |  Direct Link  |  
  17. Wimalawansa, S.J., 2015. In the era of budgetary constraints, cost-effective management of metabolic syndrome, type 2 diabetes and obesity is essential. Curr. Res. Diabetes Obesity J., Vol. 1. .
    Direct Link  |  
  18. Wimalawansa, S.J., 2015. Escalating chronic kidney diseases of multi-factorial origin (CKD-mfo) in Sri Lanka: causes, solutions and recommendations: Update and responses. Environ. Health Prev. Med., 20: 152-157.
    CrossRef  |  Direct Link  |  
  19. Wimalawansa, S.J., 2015. Agrochemicals and chronic kidney disease of multifactorial origin: Environmentally induced occupational exposure disease. Int. J. Nephrol. Kidney Fail., 1: 1-9.
  20. Wimalawansa, S.A. and S.J. Wimalawansa, 2015. Clean water, healthy environment and preservation of watersheds: Correct, enforceable policies are essential. Jacobs J. Hydrol., 1: 3-15.
  21. Wimalawansa, S.A. and S.J. Wimalawansa, 2015. Chronic kidney disease of multifactorial origin (CKDmfo/CKDu): Escalating incidence and long-term survival estimates. J. Urol. Nephrol. Res., 2: 1-15.
  22. Wimalawansa, S. and S.J. Wimalawansa, 2015. Protection of watersheds and control of fertilisers to prevent phosphate eutrophication of reservoirs in Sri Lanka. Int. J. Res. Environ. Sci., 1: 1-18.
    Direct Link  |  
  23. Weeraratne, S. and S.J. Wimalawansa, 2015. A major irrigation project (accelerated mahaweli programme) and the chronic kidney disease of multifactorial origin in Sri Lanka. Int. J. Environ. Agric. Res., 1: 16-27.
    Direct Link  |  
  24. Smith, G. and S.J. Wimalawansa, 2015. Reconciling the irreconcilable: Micronutrients in clinical nutrition and public health. Vitamins Minerals, Vol. 4. 10.4172/2376-1318.1000e136.
    CrossRef  |  Direct Link  |  
  25. Naser, K.A. and S.J. Wimalawansa, 2015. Diabetes diet: Is glycemic index still relevant in medical nutrition therapy? SLR Diabetes Metab., 1: 1-4.
    Direct Link  |  
  26. Grant, W.B., S.J. Wimalawansa, M.F. Holick, J.J. Cannell and P. Pludowski et al., 2015. Emphasizing the health benefits of vitamin D for those with neurodevelopmental disorders and intellectual disabilities. Nutrients, 7: 1538-1564.
    CrossRef  |  PubMed  |  Direct Link  |  
  27. Grant, W.B., S.J. Wimalawansa and M.F. Holick, 2015. Vitamin D supplements and reasonable solar UVB should be recommended to prevent escalating incidence of chronic diseases. Br. Med. J, Vol. 350. .
    Direct Link  |  
  28. Wimalawansa, S.J., 2014. Stigma of obesity: A major barrier to overcome. J. Clin. Transl. Endocrinol., 1: 73-76.
    CrossRef  |  Direct Link  |  
  29. Wimalawansa, S.J., 2014. Mechanisms of developing post-traumatic stress disorder: New targets for drug development and other potential interventions. CNS Neurol. Disorders Drug Targets, 13: 807-816.
    CrossRef  |  PubMed  |  Direct Link  |  
  30. Wimalawansa, S.J., 2014. Escalating chronic kidney diseases of multi-factorial origin in Sri Lanka: Causes, solutions and recommendations. Environ. Health Prev. Med., 19: 375-394.
    CrossRef  |  PubMed  |  Direct Link  |  
  31. Wimalawansa, S.J., 2014. Controlling obesity and its complications by elimination of causes and adopting healthy habits. Adv. Med. Sci., 3: 1-15.
  32. Wimalawansa, S.J., 2014. Causes and risk factors for posttraumatic stress disorder: The importance of right diagnosis and treatment. Asian J. Med. Sci., 5: 1-13.
    Direct Link  |  
  33. Wimalawansa, S.A. and S.J. Wimalawansa, 2014. Changing agricultural practices in dry zonal areas and escalating incidences of chronic kidney disease of multi-factorial origin. Wudpecker J. Agric. Environ., 3: 110-124.
  34. Wimalawansa, S.A. and S.J. Wimalawansa, 2014. Agrochemical-related environmental pollution: Effects on human health. Global J. Biol. Agric. Health Sci., 3: 72-83.
    Direct Link  |  
  35. Wimalawansa, S.J., 2013. Visceral adiposity and cardiometabolic risks: Epidemic of abdominal obesity in north America. Res. Rep. Endocr. Disorder, 3: 17-30.
    CrossRef  |  Direct Link  |  
  36. Wimalawansa, S.J., 2013. Thermogenesis based interventions for treatment for obesity and type 2 diabetes mellitus. Expert Rev. Endocrinol. Metab., 8: 275-288.
  37. Wimalawansa, S.J., 2013. Rational food fortification programs to alleviate micronutrient deficiencies. J. Food Process. Technol., 4: 257-267.
    CrossRef  |  Direct Link  |  
  38. Wimalawansa, S.J., 2013. Purification of contaminated water with reverse osmosis: Effective solution of providing clean water for human needs in developing countries. J. Emerging Technol. Adv. Eng., 3: 75-89.
    Direct Link  |  
  39. Wimalawansa, S.J., 2013. Post-traumatic stress disorder: An under-diagnosed and under-treated entity. Compr. Res. J. Med. Med. Sci., 1: 1-12.
    Direct Link  |  
  40. Wimalawansa, S.J., 2013. Pathophysiology of obesity: Focused, cause-driven approach to control the epidemic. Global Adv. Res. J. Pharm. Pharmacol., 2: 2-12.
    Direct Link  |  
  41. Wimalawansa, S.J., 2012. Vitamin D: What clinicians would like to know. Sri Lanka J. Diabetes Endocrinol. Metab., 2: 73-88.
  42. Wimalawansa, S.J., 2012. Vitamin D in the new millennium. Curr. Osteoporosis Rep., 10: 4-15.
    CrossRef  |  PubMed  |  Direct Link  |  
  43. Wimalawansa, S.J., 2011. Vitamin D: An essential component for skeletal health. Ann. N.Y. Acad. Sci., Vol. 1240. 10.1111/j.1749-6632.2011.06374.x.
    CrossRef  |  Direct Link  |  
  44. Wimalawansa, S.J., 2010. Nitric oxide and bone. Ann. N.Y. Acad. Sci., 1192: 391-403.
    CrossRef  |  Direct Link  |  
  45. Watts, N.B., J.P. Bilezikian, P.M. Camacho, S.L. Greenspan and S.T. Harris et al., 2010. American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr. Pract., 16: 1-37.
    PubMed  |  Direct Link  |  
  46. Wimalawansa, S.J., J.P. Grimes, A.C. Wilson and D.R. Hoover, 2009. Transdermal nitroglycerin therapy may not prevent early postmenopausal bone loss. J. Clin. Endocrinol. Metab., 94: 3356-3364.
    CrossRef  |  PubMed  |  Direct Link  |  
  47. Wimalawansa, S.J., 2008. Nitric oxide: Novel therapy for osteoporosis. Expert Opin. Pharmacother., 9: 3025-3044.
    PubMed  |  
  48. Wimalawansa, S.J., 2008. Nitric oxide: New evidence for novel therapeutic indications. Expert Opin. Pharmacother., 9: 1935-1954.
    CrossRef  |  PubMed  |  Direct Link  |  
  49. Wimalawansa, S.J., 2008. Insight into bisphosphonate-associated osteomyelitis of the jaw: Pathophysiology, mechanisms and clinical management. Expert Opin. Drug Saf., 7: 491-512.
    CrossRef  |  PubMed  |  Direct Link  |  
  50. Wimalawansa, S., 2008. Bisphosphonate-associated osteomyelitis of the jaw: Guidelines for practicing clinicians. Endocr. Pract., 14: 1150-1168.
    CrossRef  |  PubMed  |  Direct Link  |  
  51. Wimalawansa, S.J., 2007. Rationale for using nitric oxide donor therapy for prevention of bone loss and treatment of osteoporosis in humans. Ann. N.Y. Acad. Sci., 1117: 283-297.
    CrossRef  |  PubMed  |  Direct Link  |  
  52. Margolis, R.N. and S.J. Wimalawansa, 2006. Novel targets and therapeutics for bone loss. Ann. N.Y. Acad. Sci., 1068: 402-409.
    CrossRef  |  Direct Link  |  
  53. Liebschner, M.A., R. Muller, S.J. Wimalawansa, C.S. Rajapakse and G.H. Gunaratne, 2005. Testing two predictions for fracture load using computer models of trabecular bone. Biophys. J., 89: 759-767.
    CrossRef  |  PubMed  |  Direct Link  |  
  54. Klein, G.L., S.J. Wimalawansa, G. Kulkarni, D.J. Sherrard, A.P. Sanford and D.N. Herndon, 2005. The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: A double-blind, randomized, controlled study. Osteoporosis Int., 16: 631-635.
    CrossRef  |  PubMed  |  Direct Link  |  
  55. Yallampalli, C., S.B. Kondapaka, P. Lanlua, S.J. Wimalawansa and P.R.R. Gangula, 2004. Female sex steroid hormones and pregnancy regulate receptors for calcitonin gene-related peptide in rat mesenteric arteries, but not in aorta. Biol. Reprod., 70: 1055-1062.
    CrossRef  |  Direct Link  |  
  56. Rajapakse, C.S., J.S. Thomsen, J.S.E. Ortiz, S.J. Wimalawansa, E.N. Ebbesen, L. Mosekilde and G.H. Gunaratne, 2004. An expression relating breaking stress and density of trabecular bone. J. Biomech., 37: 1241-1249.
    CrossRef  |  PubMed  |  Direct Link  |  
  57. Penchalaneni, J., S.J. Wimalawansa and C. Yallampalli, 2004. Adrenomedullin antagonist treatment during early gestation in rats causes fetoplacental growth restriction through apoptosis. Biol. Reprod., 71: 1475-1483.
    CrossRef  |  Direct Link  |  
  58. Gangula, P.R.R., P. Lanlua, R.D. Bukoski, S.J. Wimalawansa and C. Yallampalli, 2004. Mesenteric arterial relaxation to calcitonin gene-related peptide is increased during pregnancy and by sex steroid hormones. Biol. Reprod., 71: 1739-1745.
    CrossRef  |  PubMed  |  Direct Link  |  
  59. Chauhan, M., P.R.R. Gangula, S.J. Wimalawansa and C. Yallampalli, 2004. Studies on the effects of the n-terminal domain antibodies of calcitoninreceptor-like receptor and receptor activity-modifying protein 1 on calcitoningene-related peptide-induced vasorelaxation in rat uterine artery. Biol. Reprod., 70: 1658-1663.
    CrossRef  |  Direct Link  |  
  60. Witlin, A.G., P.R. Gangula, S.J. Wimalawansa, M. Grafe, J.J. Grady and C. Yallampalli, 2003. Adrenomedullin requires an intact nitric oxide system to function as an endogenous vasodilator in rat gestation. Hypertens. Pregnancy, 22: 9-24.
    CrossRef  |  PubMed  |  Direct Link  |  
  61. Vandevska-Radunovic, V., I. Fristad, S.J. Wimalawansa and I.H. Kvinnsland, 2003. CGRP1 and NK1 receptors in postnatal, developing rat dental tissues. Eur. J. Oral Sci., 111: 497-502.
    CrossRef  |  PubMed  |  Direct Link  |  
  62. Qing, X., S.J. Wimalawansa and I.M. Keith, 2003. Specific N-terminal CGRP fragments mitigate chronic hypoxic pulmonary hypertension in rats. Regul. Pept., 110: 93-99.
    CrossRef  |  PubMed  |  Direct Link  |  
  63. Grimes, J.P. and S.J. Wimalawansa, 2003. Breast-feeding and postmenopausal osteoporosis. Current Women's Health Rep., 3: 193-198.
  64. Gangula, P.R.R., C. Thota, S.J. Wimalawansa, R.D. Bukoski and C. Yallampalli, 2003. Mechanisms involved in calcitonin gene-related peptide-induced relaxation in pregnant rat uterine artery. Biol. Reprod., 69: 1635-1641.
    CrossRef  |  
  65. Fristad, I., V. Vandevska-Radunovic, K. Fjeld, S.J. Wimalawansa and I.H. Kvinnsland, 2003. NK1, NK2, NK3 and CGRP1 receptors identified in rat oral soft tissues and in bone and dental hard tissue cells. Cell Tissue Res., 311: 383-391.
    CrossRef  |  PubMed  |  Direct Link  |  
  66. Dong, Y.L., S. Wimalawansa and C. Yallampalli, 2003. Effects of steroid hormones on calcitonin gene-related peptide receptors in cultured human myometrium. Am. J. Obstetrics Gynecology, 188: 466-472.
    CrossRef  |  PubMed  |  Direct Link  |  
  67. Chauhan, M., C.S. Thota, S.B. Kondapaka, S.J. Wimalawansa and C. Yallampalli, 2003. CGRP receptor heterogeneity: A role for receptor component protein? Trends Endocrinol. Metab., 14: 4-6.
    CrossRef  |  PubMed  |  Direct Link  |  
  68. Chauhan, M., C.S. Thota, S. Kondapaka, S. Wimalawansa and C. Yallampalli, 2003. Evidence for the existence of a new receptor for CGRP, which is not CRLR. Peptides, 24: 65-71.
    CrossRef  |  PubMed  |  Direct Link  |  
  69. Advani, S. and S.J. Wimalawansa, 2003. Bones and nutrition: Common sense supplementation for osteoporosis. Curr. Womens Health Rep., 3: 187-192.
    PubMed  |  
  70. Yallampalli, C., M. Chauhan, C.S. Thota, S. Kondapaka and S.J. Wimalawansa, 2002. Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity. Trends Endocrinol. Metab., 13: 263-269.
    CrossRef  |  PubMed  |  Direct Link  |  
  71. Witlin, A.G., Z.Y. Li, S.J. Wimalawansa, J.J. Grady, M.R. Grafe and C. Yallampalli, 2002. Placental and fetal growth and development in late rat gestation is dependent on adrenomedullin. Biol. Reprod., 67: 1025-1031.
    CrossRef  |  PubMed  |  Direct Link  |  
  72. Lanlua, P., R.D. Bukoski, S.J. Wimalawansa and C. Yallampalli, 2002. Effects of pregnancy and female sex steroid hormones on calcitonin gene-related peptide content of mesenteric artery in rats. Biol. Reprod., 67: 1430-1434.
    CrossRef  |  PubMed  |  Direct Link  |  
  73. Gunaratne, G.H., K.K. Mohanty and S.J. Wimalawansa, 2002. A model of trabecular bone and an application to osteoporosis. Phys. A Stat. Mech. Applic., 315: 98-104.
    CrossRef  |  Direct Link  |  
  74. Gunaratne, G.H., C.S. Rajapaksa, K.E. Bassler, K.K. Mohanty and S.J. Wimalawansa, 2002. Model for bone strength and osteoporotic fractures. Phys. Rev. Lett., Vol. 88. 10.1103/PhysRevLett.88.068101.
    CrossRef  |  PubMed  |  Direct Link  |  
  75. Gangula, P.R.R., Y.L. Dong, S.J. Wimalawansa and C. Yallampalli, 2002. Infusion of pregnant rats with calcitonin gene-related peptide (CGRP) 8-37, a CGRP receptor antagonist, increases blood pressure and fetal mortality and decreases fetal growth. Biol. Reprod., 67: 624-629.
    CrossRef  |  PubMed  |  Direct Link  |  
  76. Gangula, P.R.R., S.J. Wimalawansa and C. Yallampalli, 2002. Sex steroid hormones enhance hypotensive effects of calcitonin gene-related peptide in aged female rats. Biol. Reprod., 67: 1881-1887.
    CrossRef  |  PubMed  |  Direct Link  |  
  77. Dong, Y.L., S. Vegiraju, P.R. Gangula, S.B. Kondapaka, S.J. Wimalawansa and C. Yallampalli, 2002. Expression and regulation of calcitonin gene-related peptide receptor in rat placentas. Biol. Reprod., 67: 1321-1326.
    PubMed  |  Direct Link  |  
  78. Zhang, L., A.O. Hoff, S.J. Wimalawansa, G.J. Cote, R.F. Gagel and K.N. Westlund, 2001. Arthritic calcitonin/α calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivity. Pain, 89: 265-273.
    CrossRef  |  PubMed  |  Direct Link  |  
  79. Halhali, A., S.J. Wimalawansa, V. Berentsen, E. Avila, C.S. Thota and F. Larrea, 2001. Calcitonin gene- and parathyroid hormone-related peptides in preeclampsia: Effects of magnesium sulfate. Obstetrics Gynecology, 97: 893-897.
    PubMed  |  Direct Link  |  
  80. Gangula, P.R.R., H. Zhao, S.J. Wimalawansa, S.C. Supowit, D.J. DiPette and C. Yallampalli, 2001. Pregnancy and steroid hormones enhance the systemic and regional hemodynamic effects of calcitonin gene-related peptide in rats. Biol. Reprod., 64: 1776-1783.
    CrossRef  |  PubMed  |  Direct Link  |  
  81. D'este, L., S.J. Wimalawansa and T.G. Renda, 2001. Distribution of amylin-immunoreactive neurons in the monkey hypothalamus and their relationships with the histaminergic system. Arch. Histol. Cytol., 64: 295-303.
    CrossRef  |  PubMed  |  Direct Link  |  
  82. Classey, J.D., M.P. Lasalandra, Y.K. Knight, S.J. Wimalawansa and P.J. Goadsby, 2001. Immunohistochemical comparison of CGRP and substance P (peptides and receptors) and NMDAR1 and GLUR1 receptor distribution in the cat trigeminocervical complex. Cephalalgia Int. J. Headache, 21: 351-367.
  83. Yallampalli, C. and S.J. Wimalawansa, 2000. Calcitonin Gene-Related Peptide and Pregnancy. In: The CGRP Family: Calcitonin Gene-Related Peptide, Amylin and Adrenomedullin. Poyner, D., I. Marshall and S.D. Brain (Ed.). RG Landes Co., Texas, USA., pp: 229-238..
  84. Wimalawansa, S.M., V.S. Shankar, D.J. Simmins and S.J. Wimalawansa, 2000. The mechanism of bone resorption by cyclosporin: Involvement of the NO-cGMP pathway. J. Musculoskelet Neuronal Interact., 1: 141-143.
    Direct Link  |  
  85. Wimalawansa, S.M. and S.J. Wimalawansa, 2000. A novel pharmacological approach of musculoskeletal losses associated with simulated microgravity. J. Musculoskel Neuron Interact., 11: 34-41.
    Direct Link  |  
  86. Wimalawansa, S.J., 2000. Restoration of ovariectomy-induced osteopenia by nitroglycerin. Calcified Tissue Int., 66: 56-60.
    CrossRef  |  PubMed  |  Direct Link  |  
  87. Wimalawansa, S.J., 2000. Prevention and treatment of osteoporosis: Efficacy of combination of hormone replacement therapy with other antiresorptive agents. J. Clin. Densitometry, 3: 187-201.
    CrossRef  |  PubMed  |  Direct Link  |  
  88. Wimalawansa, S.J., 2000. Nitroglycerin therapy is as efficacious as standard estrogen replacement therapy (premarin) in prevention of oophorectomy-induced bone loss: A human pilot clinical study. J. Bone Mineral Res., 15: 2240-2244.
    CrossRef  |  PubMed  |  Direct Link  |  
  89. Wimalawansa, S., T. Chapa, L. Fang, C. Yallampalli, D. Simmons and S. Wimalawansa, 2000. Frequency-dependent effect of nitric oxide donor nitroglycerin on bone. J. Bone Mineral Res., 15: 1119-1125.
    CrossRef  |  PubMed  |  Direct Link  |  
  90. Morara, S., A. Rosina, L. Provini, G. Forloni, A. Caretti and S.J. Wimalawansa, 2000. Calcitonin gene-related peptide receptor expression in the neurons and glia of developing rat cerebellum: An autoradiographic and immunohistochemical analysis. Neurosci., 100: 381-391.
    CrossRef  |  Direct Link  |  
  91. Gangula, P.R.R., S.J. Wimalawansa and C. Yallampalli, 2000. Pregnancy and sex steroid hormones enhance circulating calcitonin gene-related peptide concentrations in rats. Hum. Reprod., 15: 949-953.
    CrossRef  |  PubMed  |  Direct Link  |  
  92. Gangula, P.R.R., P. Lanlua, S. Wimalawansa, S. Supowit, D. DiPette and C. Yallampalli, 2000. Regulation of calcitonin gene-related peptide expression in dorsal root ganglia of rats by female sex steroid hormones. Biol. Reprod., 62: 1033-1039.
    Direct Link  |  
  93. Gangula, P.R., H. Zhao, S.C. Supowit, S.J. Wimalawansa and D.J. Dipette et al., 2000. Increased blood pressure in α-calcitonin gene-related peptide/calcitonin gene knockout mice. Hypertens., 35: 470-475.
    CrossRef  |  PubMed  |  Direct Link  |  
  94. D'Este, L., A. Casini, S.J. Wimalawansa and T.G. Renda, 2000. Immunohistochemical localization of amylin in rat brainstem. Peptides, 21: 1743-1749.
    CrossRef  |  PubMed  |  Direct Link  |